Related Experiment Video
Updated: May 6, 2026
07:20
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
3.0K
A path model for evaluating dosing parameters for children with cerebral palsy.
Mary E Gannotti1, Jennifer B Christy, Jill C Heathcock
1M.E. Gannotti, PT, PhD, Department of Rehabilitation Sciences, University of Hartford, 200 Bloomfield Ave, West Hartford, CT 06117 (USA).
Physical Therapy
|November 16, 2013
Summary
Establishing optimal pediatric physical therapy dosing for children with cerebral palsy (CP) is crucial. A new path model guides research on intervention effectiveness, considering child, family, and community factors for improved functional independence.
Area of Science:
- Pediatric Rehabilitation
- Neurology
- Health Services Research
Background:
- Dosing of pediatric rehabilitation services for children with cerebral palsy (CP) is a national priority.
- Establishing dosing parameters is critical for clinical decision-making, health policy, and reimbursement guidelines.
Purpose of the Study:
- To describe a path model for evaluating dosing parameters of pediatric physical therapy interventions for children with CP.
- The model is designed for dose-related and effectiveness studies.
Main Methods:
- The proposed model outlines how intervention type influences the child through family and dose (frequency, intensity, time).
- It considers structural and behavioral changes leading to functional independence.
- Community factors and their influence on dose and functional independence are also incorporated.
Main Results:
- The model integrates intervention type, dose, family, child characteristics, and community factors.
- Key constructs for consideration include family and child characteristics, neuroplasticity, motor skill acquisition, and community access.
- Identifies knowledge gaps in conceptualizing dosing parameters.
Conclusions:
- A framework is provided for conceptualizing dosing parameters for pediatric physical therapy interventions in children with CP.
- The model emphasizes a holistic approach, integrating multiple factors influencing intervention outcomes.
- Further research is needed to address identified knowledge gaps in optimizing CP rehabilitation dosing.
More Related Videos
Related Concept Videos
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
491
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
491
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
398
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
398
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
231
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
231
01:28Dosage Regimens: Designs and Approaches
605
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
605